These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4940273)
1. Relative potency of intravenous prinodolol and propranolol in man. Arbab AG; Hicks DC; Turner P Br J Pharmacol; 1971 Aug; 42(4):665P-666P. PubMed ID: 4940273 [No Abstract] [Full Text] [Related]
2. Comparison of propranolol and LB 46 (prinodolol) on hyperthyroid tachycardia. Arbab AG; Turner P Postgrad Med J; 1971 Jun; 47(548):329-31. PubMed ID: 4931824 [TBL] [Abstract][Full Text] [Related]
3. [Clinical trial using the beta receptor blockader Visken]. Szám I; Holló J Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675 [No Abstract] [Full Text] [Related]
4. [Clinical studies and experiences with beta-adrenergic blocking agents in the treatment of sinus tachycardia in children]. Diekmann L Arztl Forsch; 1970 Jan; 24(1):13-8. PubMed ID: 4398686 [No Abstract] [Full Text] [Related]
5. [The treatment of tachycardial disturbances of the cardiac rhythm with a beta-adrenergic blocking agent (Visken)]. Ley H; Ohlen J; von Richthofen W Munch Med Wochenschr; 1970 Nov; 112(48):2183-6. PubMed ID: 4098955 [No Abstract] [Full Text] [Related]
6. [Decrease in ventricular frequency in auricular fibrillation using Visken]. Bender F; Dürholz HH; Gradaus D; Schmidt E Med Welt; 1971 Feb; 9():340-1. PubMed ID: 4396541 [No Abstract] [Full Text] [Related]
7. Alprenolol and propranolol in hyperthyroid tachycardia. Turner P Br J Pharmacol; 1970 Sep; 40(1):146P-147P. PubMed ID: 4395079 [No Abstract] [Full Text] [Related]
8. [Clinical trials with the beta adrenergic blocking agent Visken]. Holló J; Szám I Orv Hetil; 1972 Jun; 113(26):1530-3. PubMed ID: 5038972 [No Abstract] [Full Text] [Related]
9. Propranolol and quinidine in the management of ventricular tachycardia. Dreifus LS; Lim HF; Watanabe Y; McKnight E; Frank MN JAMA; 1968 May; 204(8):736-7. PubMed ID: 5694520 [No Abstract] [Full Text] [Related]
10. [Clinical-pharmacological studies with a new beta receptor blocking substance (LB 46, Visken)]. Judmaier G; Dienstl F; Schwingshackl H; Amor H Wien Klin Wochenschr; 1970 Dec; 82(50):891-3. PubMed ID: 5491146 [No Abstract] [Full Text] [Related]
11. A double blind trial of LB-46 in the treatment of angina pectoris. Raychaudhuri B; Das MR; Neelakatan C; Chaudhuri ND; Bose J; Chetri MK Indian Heart J; 1973 Jan; 25(1):58-61. PubMed ID: 4576304 [No Abstract] [Full Text] [Related]
12. Effect of a new adrenergic beta-blocking agent, H 56-28, on nervous heart complaints. Nordenfelt I; Persson S; Redfors A Acta Med Scand; 1968 Dec; 184(6):465-71. PubMed ID: 4885079 [No Abstract] [Full Text] [Related]
13. [Clinical observations on the use of beta-blocking agents in sinusal tachycardia]. Ravera M Minerva Cardioangiol; 1968 Oct; 16(10):1000-3. PubMed ID: 5727885 [No Abstract] [Full Text] [Related]
14. [Effect of the block of beta-adrenergic receptors in tachycardia due to thyreotoxicosis]. De Petra V; Rossi A; Maino R Cardiol Prat; 1969 Dec; 20(6):487-90. PubMed ID: 4395245 [No Abstract] [Full Text] [Related]
15. [Clinical effect of doberol. Significance for diagnosis and therapy]. Hähnel J Med Welt; 1971 Mar; 13():512-6. PubMed ID: 5563475 [No Abstract] [Full Text] [Related]
16. [Dependence of the inhibitory effect of Inderal on the increase in heart rate]. Walecka E; Kosowski Z; Romanowska-Górecka B Wiad Lek; 1971 Jul; 24(3):189-92. PubMed ID: 5548716 [No Abstract] [Full Text] [Related]